David Gutsch

1.4k total citations
16 papers, 1.2k citations indexed

About

David Gutsch is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, David Gutsch has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in David Gutsch's work include Viral-associated cancers and disorders (11 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). David Gutsch is often cited by papers focused on Viral-associated cancers and disorders (11 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). David Gutsch collaborates with scholars based in United States, Taiwan and France. David Gutsch's co-authors include Shannon C. Kenney, Q Zhang, Elizabeth Holley-Guthrie, Bruce Richardson, Donna Ray, Qin Zhang, Joseph S. Pagano, Sima J. Zacharek, Mariana J. Kaplan and Qianjin Lu and has published in prestigious journals such as Nucleic Acids Research, Blood and Molecular and Cellular Biology.

In The Last Decade

David Gutsch

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Gutsch United States	15	774	403	303	273	260	16	1.2k
Carol S. Leung United Kingdom	17	580 0.7×	561 1.4×	214 0.7×	335 1.2×	184 0.7×	25	1.1k
Gianna Ballon United States	12	462 0.6×	318 0.8×	281 0.9×	215 0.8×	327 1.3×	19	954
Gerhard Laux Germany	27	1.8k 2.4×	626 1.6×	974 3.2×	514 1.9×	387 1.5×	34	2.3k
Emiel Van Roost Belgium	11	383 0.5×	855 2.1×	162 0.5×	76 0.3×	234 0.9×	14	1.3k
R Weber-Nordt Germany	11	798 1.0×	930 2.3×	130 0.4×	110 0.4×	313 1.2×	15	1.5k
Shee Loong Loke China	9	387 0.5×	169 0.4×	204 0.7×	98 0.4×	466 1.8×	10	954
Noriko Morishima Japan	13	452 0.6×	926 2.3×	153 0.5×	103 0.4×	140 0.5×	23	1.2k
Paul Hobby United Kingdom	16	344 0.4×	954 2.4×	65 0.2×	97 0.4×	218 0.8×	24	1.3k
Haydeé L. Ramos United States	9	344 0.4×	861 2.1×	76 0.3×	81 0.3×	269 1.0×	13	1.2k
Hua-Chen Chang United States	17	393 0.5×	1.2k 3.1×	110 0.4×	79 0.3×	311 1.2×	18	1.6k

Countries citing papers authored by David Gutsch

Since Specialization

Citations

This map shows the geographic impact of David Gutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gutsch more than expected).

Fields of papers citing papers by David Gutsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gutsch. The network helps show where David Gutsch may publish in the future.

Co-authorship network of co-authors of David Gutsch

This figure shows the co-authorship network connecting the top 25 collaborators of David Gutsch. A scholar is included among the top collaborators of David Gutsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gutsch. David Gutsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Norquist, Josephine M., T. Christopher Mast, Kai‐Li Liaw, et al.. (2012). Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance. Human Vaccines & Immunotherapeutics. 8(9). 1208–1212. 16 indexed citations

Lu, Qianjin, Mariana J. Kaplan, Donna Ray, et al.. (2002). Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis & Rheumatism. 46(5). 1282–1291. 221 indexed citations

Kleer, Celina G., David Gutsch, Rosemary Rochford, et al.. (2002). Detection of Epstein-Barr Virus in Rapidly Growing Fibroadenomas of the Breast in Immunosuppressed Hosts. Modern Pathology. 15(7). 759–764. 28 indexed citations

Lu, Qianjin, Donna Ray, David Gutsch, & Bruce Richardson. (2002). Effect of DNA methylation and chromatin structure onITGAL expression. Blood. 99(12). 4503–4508. 60 indexed citations

Tan, Jun, Catherine Newton, J Y Djeu, et al.. (1996). Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.. PubMed. 56(15). 3399–403. 63 indexed citations

Gutsch, David, Kenneth B. Marcu, & Shannon C. Kenney. (1994). The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.. PubMed. 40(6). 747–60. 19 indexed citations

Gutsch, David, Elizabeth Holley-Guthrie, Qin Zhang, et al.. (1994). The bZIP Transactivator of Epstein-Barr Virus, BZLF1, Functionally and Physically Interacts with the p65 Subunit of NF-kB. Molecular and Cellular Biology. 14(3). 1939–1948. 48 indexed citations

Zhang, Q, David Gutsch, & Shannon C. Kenney. (1994). Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.. Molecular and Cellular Biology. 14(3). 1929–1938. 205 indexed citations

Zhang, Qin, David Gutsch, & Shannon C. Kenney. (1994). Functional and Physical Interaction between p53 and BZLF1: Implications for Epstein-Barr Virus Latency. Molecular and Cellular Biology. 14(3). 1929–1938. 103 indexed citations

10.

Quinlivan, E. Byrd, et al.. (1993). Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Research. 21(8). 1999–2007. 121 indexed citations

11.

Huang, Eng‐Shang, et al.. (1993). Detection of low level of human papilloma virus type 16 DNA sequences in cancer cell lines derived from two well‐differentiated nasopharyngeal cancers. Journal of Medical Virology. 40(3). 244–250. 9 indexed citations

12.

Kenney, Shannon C., Elizabeth Holley-Guthrie, E. Byrd Quinlivan, et al.. (1992). The Cellular Oncogene c- myb Can Interact Synergistically with the Epstein-Barr Virus BZLF1 Transactivator in Lymphoid Cells. Molecular and Cellular Biology. 12(1). 136–146. 24 indexed citations

13.

Holley-Guthrie, Elizabeth, et al.. (1992). The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor. Journal of Virology. 66(12). 7282–7292. 57 indexed citations

14.

Kenney, Shannon C., Elizabeth Holley-Guthrie, E. Byrd Quinlivan, et al.. (1992). The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.. Molecular and Cellular Biology. 12(1). 136–146. 46 indexed citations

15.

Kenney, Shannon C., et al.. (1991). EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. Journal of Virology. 65(5). 2164–2169. 130 indexed citations

16.

Prohaska, Joseph R. & David Gutsch. (1983). Development of glutathione peroxidase activity during dietary and genetic copper deficiency. Biological Trace Element Research. 5(1). 35–45. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact